Presentation of ITFoM in the European Parliament in Brussels, Belgium
20 September 2011
Austria
On 20 September 2011, the Information Technology: Future of Medicine (ITFoM) FET Flagship pilot project will be presented at a seminar in the European Parliament. The aim of the meeting will be to present the project to European decision makers and ensure ITFoM is a part of the future health R&D agenda of the EU in 2012 and beyond, including the Commission’s proposal for “Horizon 2020” which will be presented in November 2011. The seminar will be followed by a dinner debate on the challenges faced by ITFoM in becoming an established part of health research capacity in the EU. Issues to be addressed include the important role of research infrastructures, international cooperation and precompetitive collaborations, amongst others.
The aim of ITFoM is to create a “virtual patient” by developing general models of human pathways, tissues, and ultimately of the whole human. This will enable physicians to identify personalised prevention schedules, therapies and potential effects on individual patients. Through application in the clinic, this “virtual patient” will revolutionise medicine. The potential benefits are enormous in terms of reduction of healthcare costs as well as for each individual patient: identification of efficient drug combinations on an individual basis; substantial advances in disease prevention and treatment; better data access and use for health professionals, healthcare systems, and researchers.
ITFoM proposes medicine based on molecular, physiological, anatomical and environmental data from individual patients. This individualised and data-rich medicine poses unprecedented challenges for Information and Communications Technology in terms of hardware, storage and communication. The project brings together partners and associated members from the whole of Europe and beyond, including world leading academic institutes and multinational companies such as IBM, Intel, XEROX, Roche, Illumina, Life Technologies and Agilent.
By way of background, a recent report published by Battelle on the Human Genome Project identified the positive impact of investment in science. According to the “Economic Impact of the Human Genome Project” report, $3.8 billion invested in the project from 1988–2003 helped to generate $535.8 billion for the wider economy. The report is available at http://www.battelle.org/publications/humangenomeproject.pdf(opens in new window).
Additional information about ITFoM is available at http://www.ITFoM.eu(opens in new window).
Registration form is available at http://www.iscintelligence.com/event.php?id=41(opens in new window).
Media enquiries:
Polona Fabic
ISC Intelligence in Science
Rue du Trône 4
1000 Brussels
Belgium
Tel: +322 8888 100
Email: polona.fabic@iscintelligence.comITFoM is one of the six pilot projects preselected to become a European Future Technologies (FET) Flagship Initiatives. FET Flagships are large-scale, science-driven and mission oriented initiatives that aim to achieve visionary technological goals. To prepare the launch of the FET Flagships, the six Pilot Actions are funded with 1.5 million Euros each for a 12-month period starting in May 2011; in the second half of 2012, two of the Pilots will be selected and launched as full FET Flagship Initiatives in 2013.
The aim of ITFoM is to create a “virtual patient” by developing general models of human pathways, tissues, and ultimately of the whole human. This will enable physicians to identify personalised prevention schedules, therapies and potential effects on individual patients. Through application in the clinic, this “virtual patient” will revolutionise medicine. The potential benefits are enormous in terms of reduction of healthcare costs as well as for each individual patient: identification of efficient drug combinations on an individual basis; substantial advances in disease prevention and treatment; better data access and use for health professionals, healthcare systems, and researchers.
ITFoM proposes medicine based on molecular, physiological, anatomical and environmental data from individual patients. This individualised and data-rich medicine poses unprecedented challenges for Information and Communications Technology in terms of hardware, storage and communication. The project brings together partners and associated members from the whole of Europe and beyond, including world leading academic institutes and multinational companies such as IBM, Intel, XEROX, Roche, Illumina, Life Technologies and Agilent.
By way of background, a recent report published by Battelle on the Human Genome Project identified the positive impact of investment in science. According to the “Economic Impact of the Human Genome Project” report, $3.8 billion invested in the project from 1988–2003 helped to generate $535.8 billion for the wider economy. The report is available at http://www.battelle.org/publications/humangenomeproject.pdf(opens in new window).
Additional information about ITFoM is available at http://www.ITFoM.eu(opens in new window).
Registration form is available at http://www.iscintelligence.com/event.php?id=41(opens in new window).
Media enquiries:
Polona Fabic
ISC Intelligence in Science
Rue du Trône 4
1000 Brussels
Belgium
Tel: +322 8888 100
Email: polona.fabic@iscintelligence.comITFoM is one of the six pilot projects preselected to become a European Future Technologies (FET) Flagship Initiatives. FET Flagships are large-scale, science-driven and mission oriented initiatives that aim to achieve visionary technological goals. To prepare the launch of the FET Flagships, the six Pilot Actions are funded with 1.5 million Euros each for a 12-month period starting in May 2011; in the second half of 2012, two of the Pilots will be selected and launched as full FET Flagship Initiatives in 2013.